ISSN:
1435-604X
Keywords:
Lewis lung carcinoma
;
Pharmacokinetics
;
Spectroscopy
;
132-hydroxy bacteriopheophorbidea-methylester (132-OH-BPME)
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
,
Physics
,
Technology
Notes:
Abstract The photosensitiser 132-hydroxy bacteriopheophorbide a-methylester (132-OH-BPME) is characterised by a high absorption coefficient at the far red wavelength 750 nm and a good singlet oxygen quantum yield. The pharmacokinetics of 132-OH-BPME was studied on the Lewis lung carcinoma in mice after i.v. administration of 5 mg/kg body weight at different incubation intervals. The accumulation dye was chemically extracted from selected tissues and the concentrations were measured by absorption spectroscopy. The parenchymatous organs, liver, spleen and kidney, showed maximum 132-OH-BPME concentrations after 2 h incubation (liver, spleen) and 4 h postinjection (kidney). A high uptake was detected in the lung with the maximum concentration at 2 h. The malignant tissue accumulated high 132-OH-BPME concentrations at 2–12 h postinjection with peaking at 8 h. The 132-OH-BPME concentrations in muscle tissue, representing the normal tumour surroundings, and in the skin were very low. The results of our study suggest that photodynamic therapy (PDT) using 132-OH-BPME could be effective at an incubation time of about 8 h postsensitiser injection, when the tumour 132-OH-BPME concentration has reached its maximum and the muscle and skin concentrations are at a minimum.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00592963
Permalink